The trademark application CENRIFKI was filed by Principia Biopharma Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 25, 2022, and it was registered by office on January 5, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).